Location: Palo Alto, CA
CIK: 0001674712 · Show all filings
Period: Q1 2020 (← Previous) (Next →)
Filing Date: May 15, 2020
Total Value: $1.104B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ASND | Ascendis Pharma A/S | 2,003,147 | $226M | 20.4% | $112.61 | — | ADR | 04351P101 |
| — | New Frontier Health Corp | 14,300,000 | $118M | 10.7% | $8.25 | — | Common | G6461G106 |
| — | Kadmon Holdings Inc | 12,539,515 | $52.54M | 4.8% | $4.19 | — | Common | 48283N106 |
| ARQT | Arcutis Biotherapeutics Inc | 1,686,527 | $50.26M | 4.6% | $26.87 | 0.0% | Common | 03969K108 |
| CRNX | Crinetics Pharmaceuticals Inc | 3,320,801 | $48.82M | 4.4% | $20.50 | 0.0% | Common | 22663K107 |
| — | Zymeworks Inc | 1,101,236 | $39.06M | 3.5% | $35.47 | — | Common | 98985W102 |
| SVA | Sinovac Biotech Ltd. | 5,900,000 | $38.17M | 3.5% | $6.47 | 0.0% | SHS | P8696W104 |
| — | Forty Seven Inc | 395,691 | $37.76M | 3.4% | $95.42 | — | Common | 34983P104 |
| — | Passage Bio Inc | 2,229,587 | $35.12M | 3.2% | $15.75 | — | Common | 702712100 |
| — | Avadel Pharmaceuticals PLC | 3,575,424 | $28.39M | 2.6% | $7.94 | — | ADR | 05337M104 |
| ARWR | Arrowhead Pharmaceuticals Inc | 768,674 | $22.11M | 2.0% | $40.33 | 0.0% | Common | 04280A100 |
| — | Zogenix Inc | 888,724 | $21.98M | 2.0% | $24.73 | — | Common | 98978L204 |
| — | Verastem Inc | 8,139,535 | $21.49M | 1.9% | $2.64 | — | Common | 92337C104 |
| — | Selecta Biosciences Inc | 7,846,509 | $18.91M | 1.7% | $2.41 | — | Common | 816212104 |
| — | Sierra Oncology, Inc | 1,917,074 | $18.83M | 1.7% | $9.82 | — | Common | 82640U107 |
| — | Akero Therapeutics Inc | 808,247 | $17.14M | 1.6% | $21.20 | — | Common | 00973Y108 |
| CDXS | Codexis, Inc | 1,493,903 | $16.67M | 1.5% | $13.98 | 0.0% | Common | 192005106 |
| — | Amyris, Inc | 6,492,247 | $16.62M | 1.5% | $2.56 | — | Common | 03236M200 |
| — | Karuna Therapeutics Inc | 223,692 | $16.11M | 1.5% | $72.00 | — | Common | 48576A100 |
| — | MEI Pharma Inc | 9,784,422 | $15.75M | 1.4% | $1.61 | — | Common | 55279B202 |
| — | Homology Medicines, Inc. | 1,008,562 | $15.67M | 1.4% | $15.54 | — | Common | 438083107 |
| — | Myokardia Inc | 333,621 | $15.64M | 1.4% | $46.88 | — | Common | 62857M105 |
| — | Aduro Biotech Inc | 5,118,560 | $14.03M | 1.3% | $2.74 | — | Common | 00739L101 |
| — | Orchard Therapeutics plc | 1,627,225 | $12.25M | 1.1% | $7.53 | — | ADS | 68570P101 |
| — | Eiger BioPharmaceuticals Inc | 1,791,257 | $12.18M | 1.1% | $6.80 | — | Common | 28249U105 |
| RCKT | Rocket Pharmaceuticals Inc | 860,648 | $12.01M | 1.1% | $19.80 | 0.0% | Common | 77313F106 |
| — | Kiniksa Pharmaceuticals | 759,050 | $11.75M | 1.1% | $15.48 | — | Common | G5269C101 |
| — | Tricida, Inc. | 524,290 | $11.53M | 1.0% | $22.00 | — | Common | 89610F101 |
| ZLAB | Zai Lab Limited | 222,107 | $11.43M | 1.0% | $51.48 | — | ADR | 98887Q104 |
| KALV | KalVista Pharmaceuticals Inc. | 1,476,796 | $11.3M | 1.0% | $13.49 | 0.0% | Common | 483497103 |
| — | IGM Biosciences Inc | 199,626 | $11.21M | 1.0% | $56.15 | — | Common | 449585108 |
| — | Avrobio Inc | 717,753 | $11.17M | 1.0% | $15.56 | — | Common | 05455M100 |
| — | Menlo Therapeutics Inc. | 3,843,824 | $10.3M | 0.9% | $2.68 | — | Common | 586858102 |
| — | Trillium Therapeutics Inc | 2,054,468 | $8.3M | 0.8% | $4.04 | — | Common | 89620X506 |
| COLL | Collegium Pharmaceutical Inc | 447,173 | $7.302M | 0.7% | $20.64 | 0.0% | Common | 19459J104 |
| AUPH | Aurinia Pharmaceuticals Inc. | 500,732 | $7.266M | 0.7% | $17.64 | 0.0% | Common | 05156V102 |
| — | Kala Pharmaceuticals, Inc. | 786,883 | $6.917M | 0.6% | $8.79 | — | Common | 483119103 |
| — | Matinas Biopharma Hldgs Inc | 11,279,323 | $6.77M | 0.6% | $0.60 | — | Common | 576810105 |
| BDTX | Black Diamond Therapeutics Inc | 252,119 | $6.29M | 0.6% | $30.22 | 0.0% | Common | 09203E105 |
| — | Verona Pharma PLC | 1,492,951 | $6.151M | 0.6% | $4.12 | — | ADS | 925050106 |
| — | Soleno Therapeutics, Inc. | 2,021,377 | $4.811M | 0.4% | $2.38 | — | Common | 834203200 |
| — | Chiasma Inc | 1,272,156 | $4.643M | 0.4% | $3.65 | — | Common | 16706W102 |
| XENE | Xenon Pharmaceuticals Inc | 396,589 | $4.497M | 0.4% | $14.24 | 0.0% | Common | 98420N105 |
| — | Constellation Pharmaceutical | 140,298 | $4.41M | 0.4% | $31.43 | — | Common | 210373106 |
| RVMD | Revolution Medicines Inc | 199,518 | $4.371M | 0.4% | $27.68 | 0.0% | Common | 76155X100 |
| — | Galmed Pharmaceuticals Ltd | 860,103 | $2.976M | 0.3% | $3.46 | — | SHS | M47238106 |
| ATRC | Atricure Inc | 64,573 | $2.169M | 0.2% | $35.95 | 0.0% | Common | 04963C209 |
| ACRS | Aclaris Therapeutics, Inc. | 1,647,214 | $1.713M | 0.2% | $1.36 | 0.0% | Common | 00461U105 |
| — | Cymabay Therapeutics Inc | 1,077,467 | $1.595M | 0.1% | $1.48 | — | Common | 23257D103 |
| QURE | Uniqure NV | 22,932 | $1.088M | 0.1% | $57.46 | 0.0% | Common | N90064101 |
| — | DBV Technologies S.A. | 269,995 | $1.058M | 0.1% | $3.92 | — | ADR | 23306J101 |
| — | Nabriva Therapeutics AG | 1,704,130 | $980K | 0.1% | $0.58 | — | SHS | G63637105 |
| — | Precision Biosciences Inc | 140,255 | $846K | 0.1% | $6.03 | — | Common | 74019P108 |